SGLT-2 inhibitor-related adverse events that can complicate their use include transient mild dehydration, urinary tract infections, genital mycotic infections, and rarely euglycemic diabetic ketoacidosis (DKA) [77]. Here, SLC5A2 is linked to urinary tract infection.